Mosaic tumor vessels: Cellular basis and ultrastructure of focal regions lacking endothelial cell markers

Cancer Research

Volumn 65, Issue 13, 2005, Pages 5740-5749

  Di Tomaso, Emmanuelle ^a   Capen, Diane ^a   Haskell, Amy ^b   Hart, Janet ^a   Logie, James J ^a   Jain, Rakesh K ^a   McDonald, Donald M ^b   Jones, Rosemary ^a   Munn, Lance L ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; CD31 ANTIGEN; ENDOGLIN; MEMBRANE PROTEIN; TUMOR MARKER; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY LABELING; ARTICLE; BASEMENT MEMBRANE; CELL ULTRASTRUCTURE; COLON CARCINOMA; CONFOCAL MICROSCOPY; ENDOTHELIUM CELL; FEMALE; HUMAN; HUMAN CELL; IMMUNOREACTIVITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRANSMISSION ELECTRON MICROSCOPY; TUMOR VASCULARIZATION; TUMOR XENOGRAFT;

ANIMALS; ANTIGENS, CD; ANTIGENS, CD31; BASEMENT MEMBRANE; BLOOD VESSELS; CELL LINE, TUMOR; COLONIC NEOPLASMS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MICE; MICE, SCID; MICROSCOPY, CONFOCAL; MICROSCOPY, ELECTRON; NEOPLASM TRANSPLANTATION; NEOVASCULARIZATION, PATHOLOGIC; RECEPTORS, CELL SURFACE; TRANSPLANTATION, HETEROLOGOUS; VASCULAR CELL ADHESION MOLECULE-1;

EID: 21344443061     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-04-4552     Document Type: Article

References (36)

1. Winkler F, Kozin SV, Tong RT, et al. Kinetics of vascular normalization by VEGFR2 blockade governs brain tumor response to radiation: role of oxygenation, angiopoietin-1 and matrix metalloproteinases. Cancer Cell 2004;6:553-63.
2. Warren BA, Shubik P. The growth of the blood supply to melanoma transplants in the hamster cheek pouch. Lab Invest 1966;15:464-78.
3. Hammersen F, Endrich B, Messmer K. The fine structure of tumor blood vessels. I. Participation of non-endothelial cells in tumor angiogenesis. Int J Microcirc Clin Exp 1985;4:31-43.
4. Hashizume H, Baluk P, Morikawa S, et al. Openings between defective endothelial cells explain tumor vessel leakiness. Am J Pathol 2000;156:1363-80.
5. Jain RK, Booth MF. What brings pericytes to tumor vessels? J Clin Invest 2003;112:1142-51.
6. Morikawa S, Baluk P, Kaidoh T, Haskell A, Jain RK, McDonald DM. Abnormalities in pericytes on blood vessels and endothelial sprouts in tumors. Am J Pathol 2002;160:985-1000.
7. Baluk P, Morikawa S, Haskell A, Mancuso M, McDonald DM. Abnormalities of basement membrane on blood vessels and endothelial sprouts in tumors. Am J Pathol 2003;163:1801-15.
8. Chang YS, diTomaso E, McDonald DM, Jones RC, Jain RK, Munn LL. Mosaic blood vessels in tumors: frequency of cancer cells in contact with flowing blood. Proc Natl Acad Sci U S A 2000;97:14608-13.
9. Baluk P, Hashizume H, McDonald DM. Cellular abnormalities of blood vessels as targets in cancer. Curr Opin Genet Dev 2005;15:102-11.
10. Jain RK. Normalizing tumor vasculature with antiangiogenic therapy: a new paradigm for combination therapy. Nat Med 2001;7:987-9.
11. Jain RK. Normalization of tumor vasculature: An emerging concept in anti-angiogcnic therapy. Science 2005;307:58-62.
12. Patan S, Tanda S, Roberge S, Jones RC, Jain RK, Munn LL. Vascular morphogenesis and remodeling in a human tumor xenograft Blood vessel formation and growth after ovariectomy and tumor implantation. Circ Res 2001;89:732-9.
13. Kristjansen PE, Roberge S, Lee I, Jain RK. Tissue-isolated human tumor xenografts in athymic nude mice. Microvasc Res 1994;48:389-402.
14. Feng D, Nagy JA, Pyne K, Dvorak HF, Dvorak AM. Ultrastructural localization of platelet endothelial cell adhesion molecule (PECAM-1, CD31) in vascular endothelium. J Histochem Cytochem 2004;52:87-101.
15. Seon BK, Matsuno F, Haruta Y, Kondo M, Barcos M. Long-lasting complete inhibition of human solid tumors in SCID mice by targeting endothelial cells of tumor vasculature with antihuman endoglin immunotoxin. Clin Cancer Res 1997;3:1031-44.
16. Kumar S, Ghellal A, Li C, et al. Breast carcinoma: vascular density determined using CD105 antibody correlates with tumor prognosis. Cancer Res 1999;59:856-61.
17. Jones R. Ultrastructural analysis of contractile cell development in lung microvessels in pulmonary hypertension. Fibroblasts and intermediate cells selectively reorganize nonmuscular segments. Am J Pathol 1992;141:1491-505.
18. Jones R, Steudel W, White S, Jacobson M, Low R. Microvessel precursor cells express head-inserted smooth muscle myosin heavy chain (SM-B) isoform in hyperoxic pulmonary hypertension. Cell Tissue Res 1999;295:453-65.
19. Sundberg C, Nagy JA, Brown LF, et al. Glomeruloid microvascular proliferation follows adenoviral vascular permeability factor/vascular endothelial growth factor-164 gene delivery. Am J Pathol 2001;158:1145-60.
20. Inai T, Mancuso M, Hashizume H, et al. Inhibition of vascular endothelial growth factor (VEGF) signaling in cancer causes loss of endothelial fenestrations, regression of tumor vessels, and appearance of basement membrane ghosts. Am J Pathol 2004;165:35-52.
21. Jain RK. Molecular regulation of vessel maturation. Nat Med 2003;9:685-93.
22. Munn LL. Aberrant vascular architecture in tumors and its importance in drug-based therapies. Drug Discov Today 2003;8:396-403.
23. Hobbs SK, Monsky WL, Yuan F, et al. Regulation of transport pathways in tumor vessels: role of tumor type and microenvironment Proc Natl Acad Sci U S A 1998;95:4507-12.
24. Pettersson A, Nagy J, Brown L, et al. Heterogeneity of the angiogenic response induced in different normal adult tissues by vascular permeability factor/ vascular endothelial growth factor. Lab Invest 2000;80:99-115.
25. Leach L, Eaton BM, Westcott ED, Firth JA. Effect of histamine on endothelial permeability and structure and adhesion molecules of the paracellular junctions of perfused human placental microvessels. Microvasc Res 1995;50:323-37.
26. Raab M, Daxecker H, Markovic S, Karimi A, Griesmacher A, Mueller MM. Variations of adhesion molecule expression on human umbilical vein endothelial cells upon multiple cytokine application. Clin Chim Acta 2002;321:11-6.
27. Watts ME, Parkins CS, Chaplin DJ. Influence of hypoxia on tumour-conditioned medium on endothelial cell adhesion molecule expression in vitro. Anticancer Res. 2002;22:953-8.
28. Holash J, Maisonpierre P, Compton D, et al. Vessel cooption, regression, and growth in tumors mediated by angiopoietins and VEGF. Science 1999;284:1994-8.
29. Sephel GC, Kennedy R, Kudravi S. Expression of capillary basement membrane components during sequential phase of wound angiogenesis. Matrix Biol 1996;15:263-79.
30. Yuan F, Salehi HA, Boucher Y, Vasthare US, Tuma RF, Jain RK. Vascular permeability and microcirculation of gliomas and mammary carcinomas transplanted in rat and mouse cranial windows. Cancer Res 1994;54:4564-8.
31. Fukumura D, Yuan F, Monsky WL, Chen Y, Jain RK. Effect of host microenvironment on the microcirculation of human colon adenocarcinoma. Am J Pathol 1997;151:679-88.
32. Sood AK, Fletcher MS, Zahn CM, et al. The clinical significance of tumor cell-lined vasculature in ovarian carcinoma: implications for anti-vasculogenic therapy. Cancer Biol Ther 2002;1:661-4.
33. Rybak SM, Sanovich E, Hollingshead MG, et al. "Vasocrine" formation of tumor cell-lined vascular spaces: implications for rational design of antiangiogenic therapies. Cancer Res 2003;63:2812-9.
34. Klement G, Baruchel S, Rak J, et al. Continuous low-dose therapy with vinblastine and VEGF receptor-2 antibody induces sustained tumor regression without overt toxicity. J Clin Invest 2000;105:R15-24.
35. Man S, Bocci G, Francia G, et al. Antitumor effects in mice of low-dose (metronomic) cyclophosphamide administered continuously through the drinking water. Cancer Res 2002;62:102731-5.
36. Browder T, Butterfield CE, Kraling BM, et al. Antiangiogenic scheduling of chemotherapy improves efficacy against experimental drug-resistant cancer. Cancer Res 2000;60:1878-88.